Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Recessive mutations in the <i>CAPN1</i> gene have recently been identified in spastic paraplegia 76 (SPG76), a complex hereditary spastic paraplegia (HSP) that is combined with cerebellar ataxia, resulting in an ataxia‐spasticity disease spectrum. This study aims to assess the influence of <i>CAPN1</i> variants on the occurrence of SPG76 and identify factors potentially contributing to phenotypic heterogeneity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We screened a cohort of 240 unrelated HSP families for variants in <i>CAPN1</i> using high‐throughput sequencing analysis. We described in detail the clinical and genetic features of the SPG76 patients in our cohort and summarized all reported cases. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Six unreported <i>CAPN1</i>‐associated families containing eight patients with or without cerebellar ataxia were found in our cohort of HSP cases. These patients carried three previously reported homozygous truncating mutations (p.V64Gfs<sup>*</sup>103, c.759+1G>A, and p.R285<sup>*</sup>), and three additional novel compound heterozygous missense mutations (p.R481Q, p.P498L, and p.R618W). Lower limbs spasticity, hyperreflexia, and Babinski signs developed in about 94% of patients, with ataxia developing in 63% of cases. In total, 33 pathogenic mutations were distributed along the three reported functional domains of calpain‐1 protein, encoded by <i>CAPN1,</i> with no hotspot region. A comparison of gender distribution between the two groups indicated that female SPG76 patients were significantly more likely to present with complicated HSP than male patients (<i>P</i> = 0.015). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Interpretation</h3><p>Our study supports the clinically heterogeneous inter‐ and intra‐family variability of SPG76 patients, and demonstrates that gender and calpain‐1 linker structure may contribute to clinical heterogeneity in SPG76 cases.</p></section>

Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Two Novel Homozygous Mutations of CAPN1 in Chinese Patients with Hereditary Spastic Paraplegia and Literatures Review

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Expansion of the Phenotypic Spectrum of SPG6 Caused by Mutation in NIPA1.

Three Novel Mutations of the Spastin Gene in Chinese Patients with Hereditary Spastic Paraplegia

Receptor Expression-Enhancing Protein 1 Gene (SPG31) Mutations Are Rare in Chinese Han Patients with Hereditary Spastic Paraplegia.

[The Clinical Characteristics of a Pedigree with Incompletely Penetrated Autosomal Dominant Hereditary Spastic Paraplegia and Its Exclusion Analysis of Genetic Loci].

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

Analysis on Mutations of Spastin, Atlastin and Paraplegin Genes in Chinese Patients with Hereditary Spastic Paraplegia

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families.

Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese

Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

A Novel SPAST Gene Mutation Identified in a Chinese Family with Hereditary Spastic Paraplegia

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia

Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia

Clinical Features and Genetic Spectrum in Chinese Patients with Recessive Hereditary Spastic Paraplegia

A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics